Issue 129  /  July 10, 2026  /  7 min read

$2 Million Verdict in Stillbirth Malpractice Case

Plus: New tool targets maternal-fetal teams, postpartum breast cancers may be more aggressive, and women's health funding reviewed.

Fogg Law Group obtained a $2,000,000 jury verdict in a medical malpractice lawsuit, highlighting significant financial risks for healthcare providers in maternal-health cases. This comes as Trice Imaging launches Trice Workspace Reporting, an AI-ready, EHR-interoperable tool to manage increasingly complex pregnancies, connecting imaging, reporting, and longitudinal patient data for clinicians. Additionally, research from UCLA Health Jonsson Comprehensive Cancer Center suggests postpartum breast cancer may be biologically more aggressive, with women diagnosed within three years of childbirth nearly three times more likely to fall into a higher recurrence score category, indicating distinct features in a unique window after childbirth. Five takes inside, plus a quick-hits roundup.

— The Luteal
In Today's Brief
Deals & Funding
VIA FutureFemHealth

Q2 2026: women's health funding in review

FutureFemHealth tracked US$738.78 million invested across 40 women's health funding rounds in Q2 2026. The average disclosed deal size was $19.96 million across 37 deals. CREATE Medicines ($122m) and Nourish ($100m) secured the largest investments, together accounting for 30% of all tracked funding. 60% of funding supported conditions disproportionately affecting women, rather than female-specific conditions, providing key market insights for investors and operators.

Read the full story →
— The Luteal Editorial Team
Industry News
VIA FemTech World

New reporting tool targets maternal-fetal teams as pregnancy complexity rises

Trice Imaging launched Trice Workspace Reporting, a new tool for obstetrics and maternal-fetal medicine. The tool connects imaging, reporting, and longitudinal patient data in a single, AI-ready, EHR-interoperable workflow. Trice Imaging aims to accelerate standardized report turnaround and improve operational efficiency for fetal medicine services.

Read the full story →
— The Luteal Editorial Team
Clinical & Research
VIA FemTech World

Postpartum breast cancers may be biologically more aggressive, new study finds

A study of 385 women aged 45 or younger with early-stage breast cancer found women diagnosed within three years of childbirth were nearly three times more likely to fall into a higher recurrence score category. Those diagnosed within the first year after childbirth had significantly higher recurrence scores than those who had never given birth. These findings suggest postpartum breast cancer may be a distinct form of the disease with aggressive biological features during a unique window after childbirth, implying a need for greater consideration of postpartum status when assessing breast cancer in younger women.

Read the full story →
— The Luteal Editorial Team
Quick Hits